Click to add image

James E. Lundeen, Sr., BSEE, MS, MD has degrees in Electrical Engineering, Chemistry and Medicine.  Dr. Lundeen’s invention, “System for Controlling Pressure in Defined Environment and Associated Method” U.S. Patent 7,926,483, is the culmination of his degrees in medicine, chemistry and engineering, combined with his empathy for the injured workers whom he treated. In clinical medicine, he has conducted 275,000 exams spanning 26 years for patients with chronic pain resulting from injuries, and in many cases, correlated the exacerbation of their symptoms to weather related and specifically to barometric pressure related changes.

He has also developed Industry Standard receptor-binding analysis software (Lundon Software, Inc.) which has created computer programs to analyze data for breast cancer research and the pharmaceutical industry.  To the credit of Lundon Software, Inc., there are more than 200 U.S. pharmaceutical patents which cite the use of Lundon Software products, including the Lundon, ReceptorFit and AccuFit series, as the software employed in the analysis of enzyme or drug receptor binding data.  The products of Lundon Software, Inc. utilize proprietary powerful, rigorous, exact physical chemical equations performing non-linear least squares regression analysis which provided results integral to the integrity of the research and ultimate issuance of the aforementioned U.S. patents.

In August of 2015, two months before The Wall Street Journal wrote its explosive article giving rise to the Theranos scandal, Dr. Lundeen authored a blog post entitled “Blood Testing by the Drop” in which he explained based upon his deep understanding of science and the physics of fluid the unlikelihood of a high degree of accuracy of such testing in most cases for some time to come.  The Wall Street Journal later offered a similar conclusion based upon investigative journalism which included discussions with a former senior employee of Theranos, among others.

His Master's Thesis in computational chemistry involved the study of molecular orbital calculations of heterocyclic molecules, the building blocks for active pharmaceutical compounds. He has broad knowledge of the steps in new drug development, from molecular modeling to receptor binding studies to toxicology studies to clinical trials from his education, training, experience and special knowledge of the mathematics involved in computational chemistry.

Additionally, he has developed treatment protocols for controlling fecal incontinence, urinary incontinence and irritable bowel syndrome (IBS) utilizing side-effects of medicines.

Dr. Lundeen received his Medical Degree from the University of Health Sciences, The Chicago Medical School and training at the Mayo Clinic and the Cleveland Clinic, his M.S. in Chemistry from The Illinois State University and his B.S. in Electrical/Biomedical Engineering from the University of Illinois.  Dr. Lundeen received The Dr. John J. Sheinin Research Award for Originality and Creativity in a Research Project, Chicago Medical School, leading to his development of Lundon Software, Inc.

A select list of the institutions at which Dr. Lundeen has lectured and his publications are as follows:

The National Institutes of Health (NIH), Bethesda, Maryland

The University of Oregon, School of Pharmacy, Eugene, Oregon

The Brown Cancer Center, Louisville, Kentucky

The Society for Neuroscience

The National Groundwater Association at The 3rd International Conference of Pharmaceuticals and Endocrine Disrupting Chemicals in Water Minneapolis/St. Paul, Minnesota    Link to Text Submission of Lecture

Publications:

 

James E. Lundeen and John H. Gordon. Computer Analysis of Binding Data in Receptor Binding in Drug Research, ed. Robert O'Brien, (section head) biochemical pharmacology Hoffman LaRoche, Inc.), Marcel Dekker Company. June 1986.  Link to Full Text

 

James E. Lundeen and J. E. House. Jr. A Weighted Least Square Computation of the Antoine Constants from Vapor Pressure Data using a Microcomputer. Thermochemica Acta, 75 (1984).    Link to Abstract

 

James E. Lundeen and J. E. House, Jr. An Ion Grouping Method for Calculating the Madelung Constant for the Sodium Chloride Lattice, Thermochemica Acta , 31, (1979) 251-7.  Link to Abstract 

James E. Lundeen, Sr., BSEE, MS, MD,

Inventor

U.S. Patent 7,926,483